The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Molecular and Cellular Basis of Cardiovascular Gender Differences
Abstract
Cardiovascular diseases (CVDs), the major cause of morbidity and mortality for both men and women, occur uncommonly in premenopausal women, but their incidence rises sharply after the menopausal transition. Cardiovascular gender differences are apparent long before CVDs appear in men and women, and improved understanding of the biology underlying these differences has the potential to advance the diagnosis and treatment of CVDs in both sexes. This review considers gender differences in the molecular and cellular physiology of the heart and blood vessels in health and disease, highlighting understudied areas that can help resolve the current controversy regarding hormone replacement therapy and improve cardiovascular health in women.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Inflammation, Atherosclerosis, and Coronary Artery Disease
Hansson, G. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043430 · Cited by 8,773
Levy, D., Garrison, R. J., Savage, D. D., Kannel, W. B., & Castelli, W. P. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005313222203 · Cited by 5,699
The Protective Effects of Estrogen on the Cardiovascular System
Mendelsohn, M. E., & Karas, R. H. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906103402306 · Cited by 3,103
Self-citationCombinatorial Control of Gene Expression by Nuclear Receptors and Coregulators
McKenna, N. J., & O'Malley, B. W. (2002) · Cell · doi:10.1016/s0092-8674(02)00641-4 · Cited by 1,463
Björnström, L., & Sjöberg, M. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0486 · Cited by 1,362
Gender differences in the regulation of blood pressure
Reckelhoff, J. F. (2001) · Hypertension · doi:10.1161/01.hyp.37.5.1199 · Cited by 1,268
Coregulator Function: A Key to Understanding Tissue Specificity of Selective Receptor Modulators
Smith, C. L., & O’Malley, B. W. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0023 · Cited by 931
Risks of testosterone-replacement therapy and recommendations for monitoring.
Rhoden, E. L., & Morgentaler, A. (2004) · New England Journal of Medicine · doi:10.1056/nejmra022251 · Cited by 705
Androgens and Cardiovascular Disease
Liu, P. Y., Death, A. K., & Handelsman, D. J. (2003) · Endocrine Reviews · doi:10.1210/er.2003-0005 · Cited by 695
Cited by
Meschia, J. F., Bushnell, C., Boden-Albala, B., Braun, L. T., Bravata, D. M., Chaturvedi, S., Creager, M. A., Eckel, R. H., Elkind, M. S. V., Fornage, M., et al. (2014) · Stroke · doi:10.1161/str.0000000000000046 · Cited by 2,650
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
Kautzky-Willer, A., Harreiter, J., & Pacini, G. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1137 · Cited by 2,043
Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause
Rossouw, J. E., Prentice, R. L., Manson, J. E., Wu, L., Barad, D., Barnabei, V. M., Ko, M., LaCroix, A. Z., Margolis, K. L., & Stefanick, M. L. (2007) · JAMA · doi:10.1001/jama.297.13.1465 · Cited by 1,741
Manson, J. E., Chlebowski, R. T., Stefanick, M. L., Aragaki, A. K., Rossouw, J. E., Prentice, R. L., Anderson, G., Howard, B. V., Thomson, C. A., LaCroix, A. Z., et al. (2013) · JAMA · doi:10.1001/jama.2013.278040 · Cited by 1,650
The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030
Vogel, B., Acevedo, M., Appelman, Y., Bairey Merz, C. N., Chieffo, A., Figtree, G. A., Guerrero, M., Kunadian, V., Lam, C. S. P., Maas, A. H. E. M., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00684-x · Cited by 1,488
Estrogen receptors and human disease
Deroo, B. J. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27987 · Cited by 1,320
Goldstein, L. B., Bushnell, C. D., Adams, R. J., Appel, L. J., Braun, L. T., Chaturvedi, S., Creager, M. A., Culebras, A., Eckel, R. H., Hart, R. G., et al. (2011) · Stroke · doi:10.1161/str.0b013e3181fcb238 · Cited by 1,306
The G-protein-coupled estrogen receptor GPER in health and disease
Prossnitz, E. R., & Barton, M. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.122 · Cited by 925
“These protective effects are largely attributed to signaling via nuclear ERα”
BackgroundBernardo, B. C., Weeks, K. L., Pretorius, L., & McMullen, J. R. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.04.005 · Cited by 894
Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention
Albini, A., Pennesi, G., Donatelli, F., Cammarota, R., De Flora, S., & Noonan, D. M. (2010) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp440 · Cited by 839
Estrogen Therapy and Coronary-Artery Calcification
Manson, J. E., Allison, M. A., Rossouw, J. E., Carr, J. J., Langer, R. D., Hsia, J., Kuller, L. H., Cochrane, B. B., Hunt, J. R., Ludlam, S. E., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071513 · Cited by 711
Postmenopausal Hormone Therapy: An Endocrine Society Scientific Statement
Santen, R. J., Allred, D. C., Ardoin, S. P., Archer, D. F., Boyd, N., Braunstein, G. D., Burger, H. G., Colditz, G. A., Davis, S. R., Gambacciani, M., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2509 · Cited by 680
Self-citationManson, J. E., Aragaki, A. K., Rossouw, J. E., Anderson, G. L., Prentice, R. L., LaCroix, A. Z., Chlebowski, R. T., Howard, B. V., Thomson, C. A., Margolis, K. L., et al. (2017) · JAMA · doi:10.1001/jama.2017.11217 · Cited by 638
Sex Differences in Autoimmune Disease from a Pathological Perspective
Fairweather, D., Frisancho-Kiss, S., & Rose, N. R. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.071008 · Cited by 629
Where are all the female participants in Sports and Exercise Medicine research?
Costello, J. T., Bieuzen, F., & Bleakley, C. M. (2014) · European Journal of Sport Science · doi:10.1080/17461391.2014.911354 · Cited by 599
LaCroix, A. Z. (2011) · JAMA · doi:10.1001/jama.2011.382 · Cited by 538
Estrogen Signaling and Cardiovascular Disease
Murphy, E. (2011) · Circulation Research · doi:10.1161/circresaha.110.236687 · Cited by 497
Hormone-replacement therapy: current thinking
Lobo, R. A. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.164 · Cited by 484
Gender differences in drug responses
FRANCONI, F., BRUNELLESCHI, S., STEARDO, L., & CUOMO, V (2007) · Pharmacological Research · doi:10.1016/j.phrs.2006.11.001 · Cited by 454
Springer, K. W., Mager Stellman, J., & Jordan-Young, R. M. (2012) · Social Science & Medicine · doi:10.1016/j.socscimed.2011.05.033 · Cited by 411
Arnal, J.-F., Lenfant, F., Metivier, R., Flouriot, G., Henrion, D., Adlanmerini, M., Fontaine, C., Gourdy, P., Chambon, P., Katzenellenbogen, B., et al. (2017) · Physiological Reviews · doi:10.1152/physrev.00024.2016 · Cited by 418
27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen
Umetani, M., Domoto, H., Gormley, A. K., Yuhanna, I. S., Cummins, C. L., Javitt, N. B., Korach, K. S., Shaul, P. W., & Mangelsdorf, D. J. (2007) · Nature Medicine · doi:10.1038/nm1641 · Cited by 396
Gender medicine: effects of sex and gender on cardiovascular disease manifestation and outcomes
Regitz-Zagrosek, V., & Gebhard, C. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00797-4 · Cited by 386
Gender differences in the cardiovascular effect of sex hormones
Vitale, C., Mendelsohn, M. E., & Rosano, G. M. C. (2009) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2009.105 · Cited by 368
Self-citationPlasma membrane estrogen receptors
Levin, E. R. (2009) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2009.06.009 · Cited by 365
Vegeto, E., Benedusi, V., & Maggi, A. (2008) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2008.04.001 · Cited by 355
Harman, S. M., Black, D. M., Naftolin, F., Brinton, E. A., Budoff, M. J., Cedars, M. I., Hopkins, P. N., Lobo, R. A., Manson, J. E., Merriam, G. R., et al. (2014) · Annals of Internal Medicine · doi:10.7326/m14-0353 · Cited by 344
Rich-Edwards, J. W., Kaiser, U. B., Chen, G. L., Manson, J. E., & Goldstein, J. M. (2018) · Endocrine Reviews · doi:10.1210/er.2017-00246 · Cited by 273
Sex differences in mechanisms of arterial stiffness
DuPont, J. J., Kenney, R. M., Patel, A. R., & Jaffe, I. Z. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14624 · Cited by 290
Vaccarino, V., Badimon, L., Corti, R., de Wit, C., Dorobantu, M., Hall, A., Koller, A., Marzilli, M., Pries, A., Bugiardini, R., et al. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvq394 · Cited by 289
Therapeutic implications of the gender-specific aspects of cardiovascular disease
Regitz-Zagrosek, V. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2032 · Cited by 284
Rocca, W. A., Grossardt, B. R., & Shuster, L. T. (2011) · Brain Research · doi:10.1016/j.brainres.2010.10.031 · Cited by 283
“…mechanisms of action of estrogen on the brain are only briefly summarized here, and the readers are referred to some recent reviews and original reports of cellular or animal studies (Mendelsohn and Karas, 2005; Morrison et al., 2006; Umetani et al., 2007; Gibbs, 2010; Henderson and Brinton, 2010).”
BackgroundEstrogen Receptor-β: Recent Lessons from in Vivo Studies
Harris, H. A. (2007) · Molecular Endocrinology · doi:10.1210/me.2005-0459 · Cited by 280
Thermal variation, thermal extremes and the physiological performance of individuals
Dowd, W. W., King, F. A., & Denny, M. W. (2015) · Journal of Experimental Biology · doi:10.1242/jeb.114926 · Cited by 271
A metabolic view on menopause and ageing
Auro, K., Joensuu, A., Fischer, K., Kettunen, J., Salo, P., Mattsson, H., Niironen, M., Kaprio, J., Eriksson, J. G., Lehtimäki, T., et al. (2014) · Nature Communications · doi:10.1038/ncomms5708 · Cited by 270
Chen, J.-Q., Cammarata, P. R., Baines, C. P., & Yager, J. D. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.06.001 · Cited by 264
Turgeon, J. L., Carr, M. C., Maki, P. M., Mendelsohn, M. E., & Wise, P. M. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0020 · Cited by 264
Self-citationMenopausal hormone therapy for the management of osteoporosis
Gosset, A., Pouillès, J.-M., & Trémollieres, F. (2021) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2021.101551 · Cited by 193
Premature menopause or early menopause and risk of ischemic stroke
Rocca, W. A., Grossardt, B. R., Miller, V. M., Shuster, L. T., & Brown, R. D. (2012) · Menopause · doi:10.1097/gme.0b013e31822a9937 · Cited by 188
“Because estrogen induces several beneficial antiatherogenetic and vasoprotective effects as well as detrimental prothrombotic and proinflammatory effects, it might modify the risk of IS differentially, based on IS subtype.(13,33,34) In addition, the balance of these differential effects might vary with age.”
BackgroundPelekanou, V., Kampa, M., Kiagiadaki, F., Deli, A., Theodoropoulos, P., Agrogiannis, G., Patsouris, E., Tsapis, A., Castanas, E., & Notas, G. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a0914-430rr · Cited by 184
Mann, G. E., Bonacasa, B., Ishii, T., & Siow, R. C. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.12.012 · Cited by 158
Is there a role for menopausal hormone therapy in the management of postmenopausal osteoporosis?
Rozenberg, S., Al-Daghri, N., Aubertin-Leheudre, M., Brandi, M.-L., Cano, A., Collins, P., Cooper, C., Genazzani, A. R., Hillard, T., Kanis, J. A., et al. (2020) · Osteoporosis International · doi:10.1007/s00198-020-05497-8 · Cited by 149
Knopp, R. H., Paramsothy, P., Retzlaff, B. M., Fish, B., Walden, C., Dowdy, A., Tsunehara, C., Aikawa, K., & Cheung, M. C. (2005) · Current Atherosclerosis Reports · doi:10.1007/s11883-005-0065-6 · Cited by 148
Sex and gender differences in myocarditis and dilated cardiomyopathy: An update
Fairweather, D., Beetler, D. J., Musigk, N., Heidecker, B., Lyle, M. A., Cooper, L. T., & Bruno, K. A. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1129348 · Cited by 124
Influence of sex hormones and phytoestrogens on heart disease in men and women
Bhupathy, P., Haines, C. D., & Leinwand, L. A. (2010) · Women s Health · doi:10.2217/whe.09.80 · Cited by 125
Novel Aspects of Endothelium-Dependent Regulation of Vascular Tone
Villar, I. C., Francis, S., Webb, A., Hobbs, A. J., & Ahluwalia, A. (2006) · Kidney International · doi:10.1038/sj.ki.5001680 · Cited by 112
Zhang, L., Rao, F., Zhang, K., Khandrika, S., Das, M., Vaingankar, S. M., Bao, X., Rana, B. K., Smith, D. W., Wessel, J., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31093 · Cited by 90
Rossouw, J. E., Cushman, M., Greenland, P., Lloyd-Jones, D. M., Bray, P., Kooperberg, C., Pettinger, M., Robinson, J., Hendrix, S., & Hsia, J. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.20.2245 · Cited by 85
Hsieh, Y.-C., Yang, S., Choudhry, M. A., Yu, H.-P., Rue, L. W., Bland, K. I., & Chaudry, I. H. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00682.2005 · Cited by 84
Acute Effects of Sex Steroid Hormones on Susceptibility to Cardiac Arrhythmias: A Simulation Study
Yang, P.-C., Kurokawa, J., Furukawa, T., & Clancy, C. E. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000658 · Cited by 75
(2007) · PubMed · Cited by 71
Regulatory Actions of Estrogen Receptor Signaling in the Cardiovascular System
Ueda, K., Adachi, Y., Liu, P., Fukuma, N., & Takimoto, E. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00909 · Cited by 60
Xu, X., Xiao, J.-C., Luo, L.-F., Wang, S., Zhang, J.-P., Huang, J.-J., Liu, M.-L., Liu, C.-G., Xu, K.-Q., Li, Y.-J., et al. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.08.041 · Cited by 53
Variation in serum biomarkers with sex and female hormonal status: implications for clinical tests
Ramsey, J. M., Cooper, J. D., Penninx, B. W. J. H., & Bahn, S. (2016) · Scientific Reports · doi:10.1038/srep26947 · Cited by 45
Novel effects of hormonal contraceptive use on the plasma proteome
Josse, A. R., Garcia-Bailo, B., Fischer, K., & El-Sohemy, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045162 · Cited by 35
“Endogenous estrogens may protect against vascular disease and atherosclerosis in young women [4,5], yet HC have also been linked to a greater risk of weight gain, cardiovascular disease, dyslipidemia, myocardial infarction, venous thromboembolism, and stroke [6–9].”
BackgroundImmune Modulation by Estrogens: Role in CNS HIV-1 Infection
Wilson, M. E., Dimayuga, F. O., Reed, J. L., Curry, T. E., Anderson, C. F., Nath, A., & Bruce-Keller, A. J. (2006) · Endocrine · doi:10.1385/endo:29:2:289 · Cited by 32
Risk of Cardiovascular Events in Mothers of Women with Polycystic Ovary Syndrome
Cheang, K. I., Nestler, J. E., & Futterweit, W. (2008) · Endocrine Practice · doi:10.4158/ep.14.9.1084 · Cited by 31
Menstrual phase and the vascular response to acute resistance exercise
Augustine, J. A., Nunemacher, K. N., & Heffernan, K. S. (2018) · European Journal of Applied Physiology · doi:10.1007/s00421-018-3815-1 · Cited by 24
Left ventricular hypertrophy in Turner syndrome: a prospective echocardiographic study
Mortensen, K. H., Gravholt, C. H., Hjerrild, B. E., Stochholm, K., & Andersen, N. H. (2012) · Echocardiography · doi:10.1111/j.1540-8175.2012.01754.x · Cited by 15
Metadata
- Authors
- Mendelsohn, M. E., & Karas, R. H.
- Venue
- Science
- Published
- 2005-06-10
- Volume
- 308
- Issue
- 5728
- Pages
- 1583-1587
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2006862162
- Cited by
- 1,101
- References
- 65
- FWCI
- 74.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.